A History of Unparalleled, Innovative Care for Patients and Families
The history of this highly specialized center dates back nearly 50 years when a grant from the Ohio Department of Health led to the creation of a dedicated hemophilia center designed to provide a comprehensive approach to treatment for patients and families.
Then called the Hemophilia Treatment Center, which opened in 1975, it introduced an extensive care regimen called Home Therapy that provided education and support for patients and families, empowering them to manage symptoms and, when possible, administer treatments from their own homes.
This personalized, relationship-based approach to hemophilia treatment had a profound impact on patients, families and the community, with unprecedented results medically and socio-economically. Highly regarded studies have found that patients diagnosed with hemophilia and who receive treatment from dedicated treatment centers generally have lower mortality rates, less hospitalizations, fewer absences from school or work, and lower healthcare costs.
Continued Growth and Successful Outcomes Through Education
Today, the experts at Ohio State’s Hemostasis and Thrombosis Treatment Center (HTC) have successfully expanded upon this groundbreaking, personalized approach to provide exceptional, nationally recognized care specifically designed to offer comprehensive treatment for patients with bleeding disorders like hemophilia.
This team of specialists and subspecialists are renowned experts in hematology, cancer, pharmacy and physical therapy — all of whom specialize in blood disorders and who reach across multiple medical disciplines to design the very best personalized treatment plans targeting each patient’s specific condition.
This multidisciplinary approach further enables HTC specialists to provide patients with convenient access to world-class treatments and interventions, specialized rehabilitative programs, sophisticated imaging, genetic testing, physical therapy, social support and community programs, pharmacy services, and much more.
The mission: To provide affordable, state-of-the-art treatment as well as to foster patient education, build public awareness and advance clinical research that benefits patients and the communities affected by hematologic disorders.
In fact, Ohio State’s HTC is one of only two comprehensive clinics in central Ohio to offer a single, convenient location where patients can learn more about their disease, review treatment options with nationally recognized hematology experts, and decide on the best personalized treatment options.
Collaborating for Successful Outcomes
For the nationally renowned team of hematology physician researchers and advanced practice providers at Ohio State’s Hemostasis and Thrombosis Center, collaboration and cooperation extend across a network of institutions. In addition to establishing a TeleHealth Medicine Clinic in Wooster, Ohio, to serve the needs of the community, their ongoing affiliations with the Central Ohio Chapter National Hemophilia Foundation, Nationwide Children’s Hospital and Akron Children’s Hospital enable these experts to join forces with other leading clinicians and scientists to discover, validate and share critical findings that lead directly to improved treatment strategies for patients diagnosed with blood-related diseases like hemophilia.
Services
The nationally renowned specialists at The Ohio State University Hemostasis and Thrombosis Treatment Center (HTC) understand that blood-related diseases like hemophilia are highly complex.
Because of that understanding, the most effective means of treating patients comes from an expert team approach from across multiple medical disciplines. These teams conduct groundbreaking studies, and through detailed observations, evaluate the latest treatments and targeted therapies.
The HTC team analyzes the genetic composition of each individual’s type of disease to determine the best possible treatment options, offering improved outcomes, faster response times and fewer side effects.
Services provided include:
- Blood disorder diagnoses, coagulation studies, continuing evaluations
- Home therapy/self-infusion instruction and recertification
- Telehealth visits
- 340B Pharmacy services to reduce medication costs
- The Ohio State University Outpatient Pharmacies, offering on-site care and delivery
- Insurance advocacy, education and assistance
- Insurance premium assistance through the Hemophilia Insurance Premium Payment Program
- Genetic counseling and testing
- Financial counseling
- Education and counseling about viral complications of disease
- Referrals for supportive services from ancillary disciplines
- Home visits
- Community referrals
- Community education and professional in-service programs
- HTC team participation and support for consumer-driven educational, advocacy or support groups/activities, including FAMOHIO and the Central Ohio Chapter National Hemophilia Foundation
Research to Advance Excellence in Patient Outcomes
For patients diagnosed with blood-related diseases like hemophilia, research and clinical trials mean hope.
Clinical research can improve overall understanding of bleeding disorders, provide ongoing safety information for different therapies and increase knowledge of genetics. The Ohio State University Hemostasis and Thrombosis Clinic (HTC) has multiple open clinical trials at any given time.
One of the many exciting research studies at Ohio State’s Hemostasis and Thrombosis Treatment Center provides a new solution for women with Von Willebrand Disease (VWD) and menorrhagia (heavy menstrual cycles).
The HTC is also conducting investigational drug trials that offer treatments for rare blood disorders, including thrombosis, Evan’s Syndrome and Idiopathic Thrombocytopenic Purpura (ITP).
The HTC also has many open registry studies that further help the experts better understand long-term trends in patients with bleeding disorders. Registries contribute to understanding the quality of life for patients with bleeding disorders as measured by factors, such as pain, health outcomes, work, activity, and mental and physical health.
Current registry studies are available for patients with the following diagnoses:
- Hemophilia A
- Hemophilia B
- Other Clotting Factor Deficiencies
- Von Willebrand Disease
- Inherited and functional platelet disorders
For a comprehensive list of current research and registry studies available through Ohio State’s Hemostasis and Thrombosis Treatment Center, or for additional information on a particular trial, please contact:
- Justin Weibel, Research Coordinator: 614-685-7243, Justin.Weibel@osumc.edu
- Abby Bartosic, Research Coordinator: 614-366-8366, Abigail.Bartosic@osumc.edu
Contact Us
The Ohio State University Hemostasis and Thrombosis Treatment Center (HTC) is located at:
320 W. 10th Ave.
M414 Starling-Loving Hall
Columbus, OH 43210
Office Hours: Monday through Friday, 8 a.m.-5 p.m. EST
Phone: 614-293-9441
Fax: 614-293-6420